Skip to content

Market sample study of Lodhra from Mumbai market samples and effectiveness of its ghanvati in Prameha

Phytochemical and Pharmacotherapeutic Study of Lodhra Symplocos racemosa Kand Twak Ghanvati in Prameha Diabetes Mellitus from Mumbai Market Samples - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106222
Enrollment
30
Registered
2026-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

K G Mittal Ayurveda College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have signed written informed consent form 2.Age 20 to 60yrs 3.Blood Sugar Level i.Fasting sugar greater than 125mg/dl and less than or equal to 250mg/dl ii.Post Prandial sugar greater than 150mg/dl and less than 350mg/dl iii.Glycosylated Hemoglobin HbA1C greter than 6.5% and less than10%

Exclusion criteria

Exclusion criteria: 1.Patients below 20 yrs and above 60yrs 2.Patients with type1 Diabetes Mellitus 3. Malignant conditions and accelerated hypertensive, patients. 4.Patients with systemic diseases 5.Patients with known complications 6.All patients having acute complications like Hyperglycemic Hypoglycaemia coma Ketoacidosis Infections like gangrene Cellulitis. 7.Immunocompromised patients. 8.Medicolegal case patient

Design outcomes

Primary

MeasureTime frame
To find out the phytochemical contituents of lodhra in Mumbai market.Timepoint: 3 months

Secondary

MeasureTime frame
1.To find out the efficacy of Lodhra kand twak ghanvati in Prameha . 2.To find the adulterants & substituents of Lodhra in Mumbai market. Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Shalini Birendrakumar Mishra

K G Mittal Ayurveda College And Hospital

drbssawant@gmail.com9768092854

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026